IMHN™ Home Page

IMHN™ Clinical Profiles Index

    The format of the Comprehensive Health Assessment Inventory (CHAI™) was specifically designed to comply with the guidelines of the Joint Commission for Accreditation of Healthcare Organizations for patient assessment and treatment planning in adolescent and adult psychiatric and substance abuse residential, partial hospitalization, and outpatient facilities.

    The purpose of this assessment instrument is to provide clinicians with a comprehensive clinical picture of each patient under their care, and to help maximize therapeutic effectiveness through careful assessment, treatment planning, relapse prevention, follow up, and aftercare.

    Recommendations made in the clinical profile generated by this inventory do not imply that existing clinical approaches should be replaced or modified. Their intent is to further promote individualization of patient treatment planning, multidisciplinary approach to assessment and treatment of each patient, patient's participation in own recovery process, and continuous monitoring and reassessment of the therapeutic process for mutual benefit of both the patient and clinical staff. Statements in the clinical profile generated by CHAI™ are hypotheses for further consideration in combination with other clinical factors utilized in therapy.

    This instrument is specifically developed for use by multidisciplinary clinical teams, promoting diagnostically focused approach to treatment, and effective patient-treatment matching.

    Intended to function as a component of the patient's medical record, the Comprehensive Health Assessment Inventory (CHAI™) can be administered either in its entirety during admission, or as individual components throughout the entire therapeutic continuum. When clinically indicated, repeated administrations of CHAI™ components further enhance the assessment process without producing test-saturation effects.

    When partial administration of CHAI™ is preferred, each completed component to be sent to the IMH-Network for scoring and interpretation should include a copy of patient's demographic data.

    The first four components of CHAI™, Parts 1, 2, 3, and 4, can be self-administered by the patient. A member of the clinical staff should be available during this process to ensure completeness of response(s), and to provide assistance when required.

    Part 5 of CHAI™ should be administered under supervision of a clinical staff member experienced in cognitive assessment.

    Part 6, the Treatment Planning Guide, should be completed as a collaborative effort between the patient and the clinical staff in charge of treatment. Treatment goals generated by CHAI™ should be in accordance and agreement with a patient's own perception of the rehabilitive process and its intended outcomes. When appropriate, the patient's family and/or significant others should also participate in formulation or the patient's treatment.

Last update 08/13/1997